Xcell Therapeutics Statistics

Total Valuation

KOSDAQ:373110 has a market cap or net worth of KRW 30.66 billion. The enterprise value is 29.24 billion.

Market Cap	30.66B
Enterprise Value	29.24B

Important Dates

The last earnings date was Monday, April 13, 2026.

Earnings Date	Apr 13, 2026
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:373110 has 17.29 million shares outstanding. The number of shares has increased by 16.46% in one year.

Current Share Class	17.29M
Shares Outstanding	17.29M
Shares Change (YoY)	+16.46%
Shares Change (QoQ)	+26.01%
Owned by Insiders (%)	12.76%
Owned by Institutions (%)	n/a
Float	14.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.73
PB Ratio	4.30
P/TBV Ratio	4.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.68
EV / Sales	15.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.82

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.77.

Current Ratio	1.81
Quick Ratio	1.36
Debt / Equity	0.77
Debt / EBITDA	n/a
Debt / FCF	-0.53
Interest Coverage	-3,161.94

Financial Efficiency

Return on equity (ROE) is -134.41% and return on invested capital (ROIC) is -49.42%.

Return on Equity (ROE)	-134.41%
Return on Assets (ROA)	-41.60%
Return on Invested Capital (ROIC)	-49.42%
Return on Capital Employed (ROCE)	-104.45%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	3.87

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-52.78%
50-Day Moving Average	1,500.14
200-Day Moving Average	2,151.95
Relative Strength Index (RSI)	68.97
Average Volume (20 Days)	315,022

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:373110 had revenue of KRW 1.95 billion and -10.93 billion in losses. Loss per share was -938.00.

Revenue	1.95B
Gross Profit	-1.97B
Operating Income	-10.85B
Pretax Income	-10.93B
Net Income	-10.93B
EBITDA	-9.15B
EBIT	-10.85B
Loss Per Share	-938.00

Full Income Statement

Balance Sheet

The company has 6.91 billion in cash and 5.49 billion in debt, giving a net cash position of 1.42 billion or 82.07 per share.

Cash & Cash Equivalents	6.91B
Total Debt	5.49B
Net Cash	1.42B
Net Cash Per Share	82.07
Equity (Book Value)	7.14B
Book Value Per Share	412.74
Working Capital	4.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.50 billion and capital expenditures -866.72 million, giving a free cash flow of -10.37 billion.

Operating Cash Flow	-9.50B
Capital Expenditures	-866.72M
Depreciation & Amortization	1.70B
Net Borrowing	-695.48M
Free Cash Flow	-10.37B
FCF Per Share	-599.54

Full Cash Flow Statement

Margins

Gross Margin	-100.87%
Operating Margin	-556.79%
Pretax Margin	-560.65%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:373110 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.46%
Shareholder Yield	-16.46%
Earnings Yield	-35.64%
FCF Yield	-33.82%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:373110 has an Altman Z-Score of -5.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.21
Piotroski F-Score	2